Edith P. Mitchell - Concepedia

Author

Edith P. Mitchell

Also Known As

Alayne D. Markland, E MITCHELL, E Mitchell, E P Mitchell, E P. Mitchell, E. Mitchell, E. P. Mitchell, E.P. Mitchell, EDITH MITCHELL, Edith Mitchell

429

Publications

18.1K

Citations

H-Index

110

Concepts

All Affiliations

Thomas Jefferson University Sidney Kimmel Cancer Center Dana-Farber Cancer Institute Massachusetts General Hospital University of Pennsylvania

About

Edith P. Mitchell is an author at Thomas Jefferson University specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	53	3K
2	Health Sciences	13	16	496
3	Public Health	5	5	201
4	Engineering	2	2	46
5	Social Sciences	2	2	45

Edith P. Mitchell

116

Publications

15.9K

Citations

H-Index

Page 1

	Year	Citations
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200 Bruce J. Giantonio, Paul J. Catalano, Neal J. Meropol, Journal of Clinical Oncology	2007	2.3K
Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer Steven J. Cohen, Cornelis J.A. Punt, Nicholas Iannotti, Journal of Clinical Oncology	2008	1.8K
Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Results From the BICC-C Study Charles S. Fuchs, John L. Marshall, Edith P. Mitchell, Journal of Clinical Oncology	2007	854
A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer J. Randolph Hecht, Edith P. Mitchell, Tarek Chidiac, Journal of Clinical Oncology	2008	851
Recommended Guidelines for the Treatment of Cancer Treatment-Induced Diarrhea Al B. Benson, Jaffer A. Ajani, Robert B. Catalano, Journal of Clinical Oncology	2004	622
Differences in breast carcinoma characteristics in newly diagnosed African–American and Caucasian patients Gloria J. Morris, Sashi Naidu, Allan Topham, Cancer	2007	597
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer Steven J. Cohen, Cornelis J.A. Punt, Nicholas Iannotti, Annals of Oncology Tumor BiologyPrognostic BiomarkersMedicineColorectal CancerPathology	2009	500
Skin Toxicity Evaluation Protocol With Panitumumab (STEPP), a Phase II, Open-Label, Randomized Trial Evaluating the Impact of a Pre-Emptive Skin Treatment Regimen on Skin Toxicities and Quality of Life in Patients With Metastatic Colorectal Cancer Mario E. Lacouture, Edith P. Mitchell, Bilal Piperdi, Journal of Clinical Oncology	2010	466
Futibatinib for <i>FGFR2</i> -Rearranged Intrahepatic Cholangiocarcinoma Lipika Goyal, Funda Meric‐Bernstam, Antoine Hollebecque, New England Journal of Medicine	2023	465
Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group Elizabeth Poplin, Yang Feng, Jordan Berlin, Journal of Clinical Oncology	2009	424

Page 1